drugset / Trial / NCT06741098
A Study of NCR100 Injection for the Treatment of Knee Osteoarthritis（ KOA）
Phase 1/2
Not yet recruiting
162 enrolled
Nuwacell Biotechnologies Co., Ltd.
Shanghai 6th People's Hospital · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
This clinical study is to investigate the safety and efficacy of NCR100 injection in subjects with knee osteoarthritis (KOA). It contains two parts dose-escalating, and blind random study in adult KOA subjects.
Timeline
- Start
- 2025-02-20
- Primary completion
- 2026-11-30
- Completion
- 2028-11-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NCR100 | Cell therapy | — | Other |